← Leaderboards
Joseph Holoshitz
University Of Michigan At Ann Arbor
$13,104,321
Attributed
$13,182,071
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$13,182,071 · 12
By mechanism
R01$10,190,944 · 5
R21$1,600,381 · 4
R61$770,292 · 1
R33$390,000 · 1
P60$230,454 · 1
Top collaborators
- Henry Isaac Mosberg1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Yatrik M Shah$14,576,569
- David Alan Fox$8,525,791
- Marie Sylvia O'Neill$6,339,430
- Steven K. Lundy$1,140,136
- Ritesh I Mistry$4,163,510
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsRheumatoid ArthritisBaseCellsIn VivoMediatingEventSignal TransductionEpitopesTransgenic MiceCodeReceptorGenesPathway InteractionsIn VitroHla-Drb1AllelesProteinsCalreticulinSeveritiesImmuneAmino Acid SequenceOsteoclastsLead
Grant awards (43)
Gene-environment interaction pathways in rheumatoid arthritis$534,214
R01 · FY2023 · AR · contact PI
Gene-environment interaction pathways in rheumatoid arthritis$528,869
R01 · FY2022 · AR · contact PI
Gene-environment interaction pathways in rheumatoid arthritis$518,188
R01 · FY2021 · AR · contact PI
Gene-environment interaction pathways in rheumatoid arthritis$534,214
R01 · FY2020 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$387,500
R01 · FY2020 · AR · contact PI
Gene-environment interaction pathways in rheumatoid arthritis$534,214
R01 · FY2019 · AR · contact PI
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseases$390,000
R33 · FY2019 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$387,500
R01 · FY2019 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$387,500
R01 · FY2018 · AR · contact PI
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseases$382,375
R61 · FY2018 · AR · contact PI
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseases$387,917
R61 · FY2017 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$387,500
R01 · FY2017 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$46,500
R01 · FY2017 · AR · contact PI
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis$341,000
R01 · FY2016 · AR · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$349,875
R01 · FY2015 · AR · contact PI
A novel mechanism of gene-environment interaction in autoimmune arthritis$193,750
R21 · FY2015 · ES · contact PI
A novel bone-destructive pathway in periodontal disease$193,750
R21 · FY2015 · DE · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$342,877
R01 · FY2014 · AR · contact PI
A novel bone-destructive pathway in periodontal disease$233,250
R21 · FY2014 · DE · contact PI
A novel mechanism of gene-environment interaction in autoimmune arthritis$233,188
R21 · FY2014 · ES · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$332,381
R01 · FY2013 · AR · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$155,500
R01 · FY2013 · AR · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$349,875
R01 · FY2012 · AR · contact PI
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis$301,783
R01 · FY2012 · GM · contact PI
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis$349,875
R01 · FY2011 · AR · contact PI
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis$301,783
R01 · FY2011 · GM · contact PI
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis$304,831
R01 · FY2010 · GM · contact PI
MHC class II-Associated Endothelial Dysfunction$173,322
R21 · FY2010 · AR · contact PI
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis$307,910
R01 · FY2009 · GM · contact PI
MHC class II-Associated Endothelial Dysfunction$206,075
R21 · FY2009 · AR · contact PI
Immune dysregulation by the rheumatoid arthritis shared epitope$166,788
R21 · FY2009 · AR · contact PI
Immune dysregulation by the rheumatoid arthritis shared epitope$200,258
R21 · FY2008 · AR · contact PI
A Class II MHC-Associated Lymphocyte Activation Defect$294,903
R01 · FY2006 · AI · contact PI
A Class II MHC-Associated Lymphocyte Activation Defect$302,000
R01 · FY2005 · AI
A Class II MHC-Associated Lymphocyte Activation Defect$302,000
R01 · FY2004 · AI
Cellular Activation Pathways in Rheumatoid Arthritis$251,038
R01 · FY2004 · AR
A Class II MHC-Associated Lymphocyte Activation Defect$302,000
R01 · FY2003 · AI
Cellular Activation Pathways in Rheumatoid Arthritis$251,038
R01 · FY2003 · AR
A Class II MHC-Associated Lymphocyte Activation Defect$302,000
R01 · FY2002 · AI
Cellular Activation Pathways in Rheumatoid Arthritis$251,038
R01 · FY2002 · AR
Cellular Activation Pathways in Rheumatoid Arthritis$251,038
R01 · FY2001 · AR
HLA-DRB1 ALLELE SPECIFIC SIGNALING ABERRATION IN RHEUMATOID ARTHRITIS$115,227
P60 · FY2001 · AR
HLA-DRB1 ALLELE SPECIFIC SIGNALING ABERRATION IN RHEUMATOID ARTHRITIS$115,227
P60 · FY2000 · AR